☰

Lori N. Griner, Ph.D. - Publications

Affiliations: 
2013 Biology (Cell Biology, Microbiology, Molecular Biology) University of South Florida, Tampa, FL, United States 
Area:
Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Basiorka AA, McGraw KL, De Ceuninck L, Griner LN, Zhang L, Clark JA, Caceres G, Sokol L, Komrokji RS, Reuther GW, Wei S, Tavernier J, List AF. Lenalidomide Stabilizes the Erythropoietin Receptor by Inhibiting the E3 Ubiquitin Ligase RNF41. Cancer Research. PMID 27197154 DOI: 10.1158/0008-5472.Can-15-1756  0.678
2015 Mazzacurati L, Lambert QT, Pradhan A, Griner LN, Huszar D, Reuther GW. The PIM inhibitor AZD1208 synergizes with ruxolitinib to induce apoptosis of ruxolitinib sensitive and resistant JAK2-V617F-driven cells and inhibit colony formation of primary MPN cells. Oncotarget. PMID 26472029 DOI: 10.18632/Oncotarget.5653  0.663
2013 Griner LN, McGraw KL, Johnson JO, List AF, Reuther GW. JAK2-V617F-mediated signalling is dependent on lipid rafts and statins inhibit JAK2-V617F-dependent cell growth. British Journal of Haematology. 160: 177-87. PMID 23157224 DOI: 10.1111/Bjh.12103  0.701
2012 Basiorka AA, McGraw KL, Griner LN, Zhang L, De Ceuninck L, Caceres G, Sokol L, Komrokji RS, Wei S, Tavernier J, List AF. Lenalidomide Upregulates Erythropoietin Receptor Expression Through Inhibition of the E3-Ubiquitin Ligase Ring Finger Protein 41 (RNF41) Blood. 120: 3455-3455. DOI: 10.1182/Blood.V120.21.3455.3455  0.475
2011 Griner LN, McGraw KL, Johnson JO, List AF, Reuther GW. A Mechanistic Rationale for the Use of Statins to Enhance JAK Inhibitor Therapy in MPNs Blood. 118: 2816-2816. DOI: 10.1182/Blood.V118.21.2816.2816  0.705
2010 Griner LN, Reuther GW. Aggressive myeloid leukemia formation is directed by the Musashi 2/Numb pathway. Cancer Biology & Therapy. 10: 979-82. PMID 21084860 DOI: 10.4161/Cbt.10.10.14010  0.625
2010 Pradhan A, Lambert QT, Griner LN, Reuther GW. Activation of JAK2-V617F by components of heterodimeric cytokine receptors. The Journal of Biological Chemistry. 285: 16651-63. PMID 20363735 DOI: 10.1074/Jbc.M109.071191  0.695
2010 Griner LN, McGraw KL, Johnson JO, List AF, Reuther GW. Requirement of Lipid Raft Integrity for Signaling by JAK2-V617F Blood. 116: 4191-4191. DOI: 10.1182/Blood.V116.21.4191.4191  0.71
2009 Pradhan AR, Lambert QT, Griner LN, Reuther GW. Activation of JAK2-V617F by Heterodimeric Receptor Components. Blood. 114: 2955-2955. DOI: 10.1182/Blood.V114.22.2955.2955  0.685
Show low-probability matches.